ECOT China

ECOT Medical is a specialized medical technology company based in Suzhou, China, focused on the research, development, and commercialization of extracorporeal life support (ECLS) systems. The company's primary offering is its proprietary Extracorporeal Membrane Oxygenation (ECMO) system, which includes centrifugal pumps, oxygenators, and sophisticated control units designed for patients with life-threatening heart or lung failure. ECOT's technology aims to provide high-performance, domestically produced alternatives to international ECMO systems, addressing a critical gap in the Chinese healthcare market. In 2023, the company achieved a significant milestone with the NMPA approval of its core ECMO system, positioning it as a key player in China's critical care medical device sector. The company continues to expand its portfolio to include various components of the extracorporeal circuit, ensuring a comprehensive solution for intensive care units. ECOT is recognized for its contribution to China's strategic goal of achieving self-sufficiency in high-end medical equipment.